Cargando…

Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries

Cervical cancer and other human papillomavirus- (HPV-) related cancers are preventable, but preventive measures implemented in developing countries and especially in low-income rural regions have not been effective. Cervical cancer burden derived from sexually transmitted HPV infections is the heavi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Natunen, Kari, Lehtinen, Johannes, Namujju, Proscovia, Sellors, John, Lehtinen, Matti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140204/ https://www.ncbi.nlm.nih.gov/pubmed/21785556 http://dx.doi.org/10.1155/2011/675858

Ejemplares similares

Cancer Registry follow‐up for 17 million person‐years of a nationwide maternity cohort
por: Lehtinen, Matti, et al.
Publicado: (2017)

Sound efficacy of prophylactic HPV vaccination: Basics and implications
por: Lehtinen, Matti, et al.
Publicado: (2012)

Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine – a pilot study
por: Namujju, Proscovia B, et al.
Publicado: (2014)

Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence
por: Namujju, Proscovia B, et al.
Publicado: (2011)

Moral dilemma(s) in human papillomavirus vaccination – revisiting the role of the herd effect
por: Lehtinen, Matti, et al.
Publicado: (2021)

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials
por: Lehtinen, Matti, et al.
Publicado: (2017)

Effectiveness of the AS04‐adjuvanted HPV‐16/18 vaccine in reducing oropharyngeal HPV infections in young females—Results from a community‐randomized trial
por: Lehtinen, Matti, et al.
Publicado: (2019)

Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
por: Man, Irene, et al.
Publicado: (2020)

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland
por: Lehtinen, Matti, et al.
Publicado: (2021)

The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland
por: Korhonen, Suvi, et al.
Publicado: (2019)

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trial
por: Lehtinen, Matti, et al.
Publicado: (2016)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses
por: Barnabas, Ruanne V, et al.
Publicado: (2006)

Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
por: Cid-Arregui, Angel
Publicado: (2009)

Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis
por: Ren, Xinyu, et al.
Publicado: (2022)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

A prospective study of the relationship between prediagnostic Human Papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas
por: Sigstad, E, et al.
Publicado: (2002)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination
por: Pimenta, Jeanne M, et al.
Publicado: (2013)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
por: Kohli, M, et al.
Publicado: (2007)

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
por: Lehtinen, Matti, et al.
Publicado: (2021)

The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years
por: Nakalembe, Miriam, et al.
Publicado: (2014)

Is the risk of cervical atypia associated with the interval between menarche and the start of sexual activity? A population-based cohort study
por: Adhikari, Indira, et al.
Publicado: (2019)

Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers
por: Nayereh, Khadem Ghaebi, et al.
Publicado: (2012)

Association between human papillomavirus vaccine status and other cervical cancer risk factors
por: Bowyer, Harriet L., et al.
Publicado: (2014)

Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study
por: Baussano, Iacopo, et al.
Publicado: (2017)

Immunopathogenesis of Chlamydial Pelvic Inflammatory Disease: The Role of Heat-Shock Proteins
por: Paavonen, Jorma, et al.
Publicado: (1994)

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
por: French, K M, et al.
Publicado: (2007)

Surgical Aspects of Rheumatic Heart Disease: The Development of Surgical Techniques over the past 20 Years
por: Sellors, T. Holmes
Publicado: (1969)

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era
por: Lehtinen, Matti, et al.
Publicado: (2022)

A Long Way: History of the Prophylactic Papillomavirus Vaccine
por: Müller, Martin, et al.
Publicado: (2007)

A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland
por: Hinkula, M, et al.
Publicado: (2004)

Human Papillomavirus and Cervical Cancer
por: Unger, Elizabeth R., et al.
Publicado: (2004)

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
por: Bjørge, T, et al.
Publicado: (2002)

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
por: Bjørge, T, et al.
Publicado: (2004)

Towards elimination of cervical cancer – human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries
por: Ong, Sok King, et al.
Publicado: (2023)

Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls
por: Bardají, Azucena, et al.
Publicado: (2018)

Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
por: Liu, Yi-Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hjdfn8cue8s48am1on78tqsrg6